PetMed Express Inc. (PETS) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
420 SOUTH CONGRESS AVENUE DELRAY BEACH, FL 33445 |
| State of Incorp. | FL |
| Fiscal Year End | March 31 |
| Industry (SIC) | 5912 - Drug Stores and Proprietary Stores (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 3/31/2024 | 12/31/2023 MRQ | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 55,296 | 49,440 | 104,086 | 111,080 | 118,718 | 103,762 | |||
| Cash and cash equivalents | 55,296 | 49,440 | 104,086 | 111,080 | 118,718 | 103,762 | |||
| Receivables | 3,283 | 1,930 | 1,740 | 1,913 | 2,587 | 3,843 | |||
| Inventory, net of allowances, customer advances and progress billings | (72) | (48) | (81) | (86) | (45) | ||||
| Inventory | (72) | (48) | (81) | (86) | (45) | ||||
| Prepaid expense | 188 | 798 | 1,883 | 681 | 959 | ||||
| Other undisclosed current assets | 34,953 | 43,381 | 23,790 | 37,402 | 39,009 | 21,458 | |||
| Total current assets: | 93,648 | 95,549 | 131,451 | 150,995 | 161,187 | 129,018 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,432 | 1,626 | |||||||
| Property, plant and equipment | 26,657 | 26,811 | 26,178 | 24,464 | 25,450 | 25,445 | |||
| Long-term investments and receivables | 5,300 | ||||||||
| Long-term investments | 5,300 | ||||||||
| Intangible assets, net (including goodwill) | 37,861 | 38,349 | 5,860 | 860 | 860 | 860 | |||
| Goodwill | 26,658 | 26,657 | |||||||
| Intangible assets, net (excluding goodwill) | 11,203 | 11,692 | 5,860 | 860 | 860 | 860 | |||
| Deferred income tax assets | 4,986 | 5,715 | 628 | ||||||
| Other undisclosed noncurrent assets | 5,300 | ||||||||
| Total noncurrent assets: | 76,236 | 77,801 | 32,666 | 25,324 | 26,310 | 26,305 | |||
| TOTAL ASSETS: | 169,884 | 173,350 | 164,117 | 176,319 | 187,497 | 155,323 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 66,390 | 63,023 | 34,097 | 33,643 | 42,732 | 22,819 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 558 | 198 | 246 | ||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 1,106 | 1,063 | 1,098 | ||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 1,134 | 1,525 | 1,242 | ||
| Accounts payable | 37,024 | 38,851 | 25,208 | 27,500 | 39,548 | 19,658 | |||
| Accrued liabilities | 29,366 | 24,172 | 8,889 | 3,345 | 398 | 575 | |||
| Deferred revenue | 2,603 | 3,068 | |||||||
| Other undisclosed current liabilities | 3,165 | 6,309 | 2,400 | (446) | 2,203 | 1,524 | |||
| Total current liabilities: | 72,158 | 72,400 | 36,497 | 33,197 | 44,935 | 24,343 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 995 | 890 | 3,825 | 936 | 1,281 | 970 | |||
| Deferred income tax liabilities | 936 | 1,281 | 970 | ||||||
| Other liabilities | 3,825 | ||||||||
| Operating lease, liability | 995 | 890 | |||||||
| Total noncurrent liabilities: | 995 | 890 | 3,825 | 936 | 1,281 | 970 | |||
| Total liabilities: | 73,153 | 73,290 | 40,322 | 34,133 | 46,216 | 25,313 | |||
| Equity | |||||||||
| Equity, attributable to parent | 96,731 | 100,060 | 123,795 | 142,186 | 141,281 | 130,010 | |||
| Preferred stock | 9 | 9 | 9 | 9 | 9 | 9 | |||
| Common stock | 21 | 21 | 21 | 21 | 20 | 20 | |||
| Additional paid in capital | 25,146 | 23,473 | 18,277 | 11,660 | 7,111 | 3,804 | |||
| Retained earnings | 71,555 | 76,557 | 105,488 | 130,496 | 134,141 | 126,177 | |||
| Total equity: | 96,731 | 100,060 | 123,795 | 142,186 | 141,281 | 130,010 | |||
| TOTAL LIABILITIES AND EQUITY: | 169,884 | 173,350 | 164,117 | 176,319 | 187,497 | 155,323 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 3/31/2024 | 12/31/2023 TTM | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 281,064 | 214,560 | 256,858 | 273,417 | 309,215 | 284,125 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (202,416) | (154,089) | (185,844) | (195,341) | (219,267) | (202,879) | ||
| Gross profit: | 78,648 | 60,471 | 71,014 | 78,076 | 89,948 | 81,246 | ||
| Operating expenses | (86,810) | (64,798) | (72,444) | (52,366) | (52,361) | (50,269) | ||
| Operating income (loss): | (8,162) | (4,327) | (1,430) | 25,710 | 37,587 | 30,977 | ||
| Nonoperating income | 1,889 | 1,534 | 3,014 | 1,361 | 1,629 | 2,916 | ||
| Investment income, nonoperating | 2,070 | 335 | 314 | 1,747 | ||||
| Other nonoperating income | 1,378 | 1,053 | 944 | 1,026 | 1,315 | 1,169 | ||
| Income (loss) from continuing operations before income taxes: | (6,273) | (2,793) | 1,584 | 27,071 | 39,216 | 33,893 | ||
| Income tax expense (benefit) | (1,191) | 345 | (1,351) | (5,971) | (8,613) | (8,042) | ||
| Income (loss) from continuing operations: | (7,464) | (2,448) | 233 | 21,100 | 30,603 | 25,851 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 21,100 | 30,603 | 25,851 | |
| Net income (loss) available to common stockholders, diluted: | (7,464) | (2,448) | 233 | 21,100 | 30,603 | 25,851 | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 3/31/2024 | 12/31/2023 TTM | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (7,464) | (2,448) | 233 | 21,100 | 30,603 | 25,851 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (7,464) | (2,448) | 233 | 21,100 | 30,603 | 25,851 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.